{"count": 7, "results": [{"_id": "35691993", "pmid": 35691993, "title": "Simvastatin inhibits prostatic hyperplasia in rats with metabolic syndrome.", "journal": "Int Urol Nephrol", "authors": ["Gong YM", "Wang X", "Liu S", "Hu XC", "Xu Y", "Huang T"], "date": "2022-09-01T00:00:00Z", "doi": "10.1007/s11255-022-03227-z", "meta_date_publication": "2022 Sep", "meta_volume": "54", "meta_issue": "9", "meta_pages": "2125-2131", "score": 50273.273, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ inhibits @<m>DISEASE_Prostatic_Hyperplasia</m> @DISEASE_MESH:D011470 @@@prostatic hyperplasia@@@ in @SPECIES_10116 @@@rats@@@ with @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@metabolic syndrome@@@.", "citations": {"NLM": "Gong YM, Wang X, Liu S, Hu XC, Xu Y, Huang T. Simvastatin inhibits prostatic hyperplasia in rats with metabolic syndrome. Int Urol Nephrol. 2022 Sep;54(9):2125-2131. PMID: 35691993", "BibTeX": "@article{35691993, title={Simvastatin inhibits prostatic hyperplasia in rats with metabolic syndrome.}, author={Gong YM and Wang X and Liu S and Hu XC and Xu Y and Huang T}, journal={Int Urol Nephrol}, volume={54}, number={9}, pages={2125-2131}}"}}, {"_id": "36902342", "pmid": 36902342, "pmcid": "PMC10003121", "title": "Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-gamma and Classic WNT/beta-Catenin Pathway", "journal": "Int J Mol Sci", "authors": ["Wang Z", "Yang S", "Li Y", "Zhou Y", "Liu D", "Liu J", "DiSanto ME", "Zhang X"], "date": "2023-03-03T00:00:00Z", "doi": "10.3390/ijms24054911", "meta_date_publication": "2023 Mar 3", "meta_volume": "24", "meta_issue": "5", "meta_pages": "", "score": 50261.668, "text_hl": "However, the specific mechanism of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SV@@@ in the development of @<m>DISEASE_Prostatic_Hyperplasia</m> @DISEASE_MESH:D011470 @@@BPH@@@ is still unclear. ", "citations": {"NLM": "Wang Z, Yang S, Li Y, Zhou Y, Liu D, Liu J, DiSanto ME, Zhang X. Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-gamma and Classic WNT/beta-Catenin Pathway Int J Mol Sci. 2023 Mar 3;24(5):. PMID: 36902342", "BibTeX": "@article{36902342, title={Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-gamma and Classic WNT/beta-Catenin Pathway}, author={Wang Z and Yang S and Li Y and Zhou Y and Liu D and Liu J and DiSanto ME and Zhang X}, journal={Int J Mol Sci}, volume={24}, number={5}}"}}, {"_id": "37164119", "pmid": 37164119, "title": "Simvastatin ameliorates testosterone-induced prostatic hyperplasia in rats via modulating IGF-1/PI3K/AKT/FOXO signaling.", "journal": "Eur J Pharmacol", "authors": ["El-Shafei NH", "Zaafan MA", "Kandil EA", "Sayed RH"], "date": "2023-07-05T00:00:00Z", "doi": "10.1016/j.ejphar.2023.175762", "meta_date_publication": "2023 Jul 5", "meta_volume": "950", "meta_issue": "", "meta_pages": "175762", "score": 50259.69, "text_hl": "This study aims to determine @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@'s beneficial effect on @CHEMICAL_Testosterone @CHEMICAL_MESH:D013739 @@@testosterone@@@-induced @<m>DISEASE_Prostatic_Hyperplasia</m> @DISEASE_MESH:D011470 @@@BPH@@@. ", "citations": {"NLM": "El-Shafei NH, Zaafan MA, Kandil EA, Sayed RH. Simvastatin ameliorates testosterone-induced prostatic hyperplasia in rats via modulating IGF-1/PI3K/AKT/FOXO signaling. Eur J Pharmacol. 2023 Jul 5;950():175762. PMID: 37164119", "BibTeX": "@article{37164119, title={Simvastatin ameliorates testosterone-induced prostatic hyperplasia in rats via modulating IGF-1/PI3K/AKT/FOXO signaling.}, author={El-Shafei NH and Zaafan MA and Kandil EA and Sayed RH}, journal={Eur J Pharmacol}, volume={950}, pages={175762}}"}}, {"_id": "1725937", "pmid": 1725937, "title": "[Pharmacologic treatment of benign prostatic hypertrophy (BPH): a combination of mepartricin and simvastatin. Analysis and results].", "journal": "Minerva Urol Nefrol", "authors": ["Marino G", "Pugno E", "Cevoli R", "Griffa D", "Pastorini S", "Cocimano V"], "date": "1991-10-01T00:00:00Z", "meta_date_publication": "1991 Oct-Dec", "meta_volume": "43", "meta_issue": "4", "meta_pages": "279-82", "score": 50078.03, "text_hl": "[Pharmacologic treatment of @<m>DISEASE_Prostatic_Hyperplasia</m> @DISEASE_MESH:D011470 @@@benign prostatic hypertrophy@@@ (@<m>DISEASE_Prostatic_Hyperplasia</m> @DISEASE_MESH:D011470 @@@BPH@@@): a combination of @CHEMICAL_Mepartricin @CHEMICAL_MESH:D008613 @@@mepartricin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@. ", "citations": {"NLM": "Marino G, Pugno E, Cevoli R, Griffa D, Pastorini S, Cocimano V. [Pharmacologic treatment of benign prostatic hypertrophy (BPH): a combination of mepartricin and simvastatin. Analysis and results]. Minerva Urol Nefrol. 1991 Oct-Dec;43(4):279-82. PMID: 1725937", "BibTeX": "@article{1725937, title={[Pharmacologic treatment of benign prostatic hypertrophy (BPH): a combination of mepartricin and simvastatin. Analysis and results].}, author={Marino G and Pugno E and Cevoli R and Griffa D and Pastorini S and Cocimano V}, journal={Minerva Urol Nefrol}, volume={43}, number={4}, pages={279-82}}"}}, {"_id": "23838355", "pmid": 23838355, "title": "Influence and pathophysiological mechanisms of simvastatin on prostatic hyperplasia in spontaneously hypertensive rats.", "journal": "Urol Int", "authors": ["Zhang X", "Shen F", "Dong L", "Zhao X", "Qu X"], "date": "2013-01-01T00:00:00Z", "doi": "10.1159/000350519", "meta_date_publication": "2013", "meta_volume": "91", "meta_issue": "4", "meta_pages": "467-73", "score": 50069.594, "text_hl": "CONCLUSIONS: @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ can delay and inhibit @<m>DISEASE_Prostatic_Hyperplasia</m> @DISEASE_MESH:D011470 @@@prostatic hyperplasia@@@ and progression in SHR. ", "citations": {"NLM": "Zhang X, Shen F, Dong L, Zhao X, Qu X. Influence and pathophysiological mechanisms of simvastatin on prostatic hyperplasia in spontaneously hypertensive rats. Urol Int. 2013;91(4):467-73. PMID: 23838355", "BibTeX": "@article{23838355, title={Influence and pathophysiological mechanisms of simvastatin on prostatic hyperplasia in spontaneously hypertensive rats.}, author={Zhang X and Shen F and Dong L and Zhao X and Qu X}, journal={Urol Int}, volume={91}, number={4}, pages={467-73}}"}}, {"_id": "25850975", "pmid": 25850975, "title": "The effects of statins on benign prostatic hyperplasia in elderly patients with metabolic syndrome.", "journal": "World J Urol", "authors": ["Zhang X", "Zeng X", "Dong L", "Zhao X", "Qu X"], "date": "2015-12-01T00:00:00Z", "doi": "10.1007/s00345-015-1550-3", "meta_date_publication": "2015 Dec", "meta_volume": "33", "meta_issue": "12", "meta_pages": "2071-7", "score": 50065.08, "text_hl": "PURPOSE: To evaluate the effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ in elderly male @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Prostatic_Hyperplasia</m> @DISEASE_MESH:D011470 @@@benign prostatic hyperplasia@@@ (@<m>DISEASE_Prostatic_Hyperplasia</m> @DISEASE_MESH:D011470 @@@BPH@@@) accompanied by @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@metabolic syndrome@@@ (@DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@MetS@@@). ", "citations": {"NLM": "Zhang X, Zeng X, Dong L, Zhao X, Qu X. The effects of statins on benign prostatic hyperplasia in elderly patients with metabolic syndrome. World J Urol. 2015 Dec;33(12):2071-7. PMID: 25850975", "BibTeX": "@article{25850975, title={The effects of statins on benign prostatic hyperplasia in elderly patients with metabolic syndrome.}, author={Zhang X and Zeng X and Dong L and Zhao X and Qu X}, journal={World J Urol}, volume={33}, number={12}, pages={2071-7}}"}}, {"_id": "21194596", "pmid": 21194596, "title": "Acute hepatitis associated with the use of levofloxacin.", "journal": "Clin Ther", "authors": ["Figueira-Coelho J", "Pereira O", "Picado B", "Mendonça P", "Neves-Costa J", "Neta J"], "date": "2010-09-01T00:00:00Z", "doi": "10.1016/j.clinthera.2010.09.004", "meta_date_publication": "2010 Sep", "meta_volume": "32", "meta_issue": "10", "meta_pages": "1733-7", "score": 50028.344, "text_hl": "The @SPECIES_9606 @@@patient@@@ had a history of @DISEASE_Bronchitis_Chronic @DISEASE_MESH:D029481 @@@chronic bronchitis@@@, arterial @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@, @DISEASE_Hypercholesterolemia @DISEASE_MESH:D006937 @@@hypercholesterolemia@@@, and @<m>DISEASE_Prostatic_Hyperplasia</m> @DISEASE_MESH:D011470 @@@benign prostatic hyperplasia@@@, and was being treated with @CHEMICAL_Salmeterol_Xinafoate @CHEMICAL_MESH:D000068299 @@@salmeterol@@@ 50 mug plus @CHEMICAL_Fluticasone @CHEMICAL_MESH:D000068298 @@@fluticasone@@@ 250 mug BID, and @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine@@@ 5 mg, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 20 mg, @CHEMICAL_alfuzosin @CHEMICAL_MESH:C047638 @@@alfuzosin@@@ 10 mg, and @CHEMICAL_Finasteride @CHEMICAL_MESH:D018120 @@@finasteride@@@ 5 mg once daily. ", "citations": {"NLM": "Figueira-Coelho J, Pereira O, Picado B, Mendonça P, Neves-Costa J, Neta J. Acute hepatitis associated with the use of levofloxacin. Clin Ther. 2010 Sep;32(10):1733-7. PMID: 21194596", "BibTeX": "@article{21194596, title={Acute hepatitis associated with the use of levofloxacin.}, author={Figueira-Coelho J and Pereira O and Picado B and Mendonça P and Neves-Costa J and Neta J}, journal={Clin Ther}, volume={32}, number={10}, pages={1733-7}}"}}]}